Ozempic approved in Canada to slow kidney decline, prevent cardiovascular disease
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.Between 30...
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.Between 30...
By Julia Cipriano, MSPosted: 8/27/2025 9:00:00 AM Last Updated: 8/26/2025 2:44:13 PM A population-based prognostic study published in JAMA Oncology...
Explanation for the choice of comparators {6b}Participants in the control group will receive matched identical placebo. A placebo-controlled trial was...
As summer heats up and tourists flock to the California coast, beachgoers should be on the lookout for sea lions...
News The TGA has approved semaglutide for reducing the risk of kidney function decline for adults with type...
Our analysis of mortality data from the CDC WONDER database, spanning two decades, reveals several key findings. First, we identified...